首页> 外文期刊>Prostaglandins, Leukotrienes, and Essential Fatty Acids >Higher baseline expression of the PTGS2 gene and greater decreases in total colonic fatty acid content predict greater decreases in colonic prostaglandin-E 2 concentrations after dietary supplementation with ω-3 fatty acids
【24h】

Higher baseline expression of the PTGS2 gene and greater decreases in total colonic fatty acid content predict greater decreases in colonic prostaglandin-E 2 concentrations after dietary supplementation with ω-3 fatty acids

机译:PTGS2基因的较高基线表达和大肠总脂肪酸含量的更大降低预测结肠前列腺素-E 2膳食补充剂ω-3脂肪酸后的结肠前列腺素-E 2浓度的更大降低

获取原文
获取原文并翻译 | 示例
           

摘要

This study evaluated whether mRNA expression of major genes regulating formation of prostaglandin (PG)E2in the colon and colonic fatty acid concentrations are associated with the reduction in colonic mucosal PGE2after dietary supplementation with omega-3 (ω-3) fatty acids. Supplementation with ω-3 fatty acids was done for 12 weeks using personalized dosing that was expected to reduce colonic PGE2by 50%. In stepwise linear regression models, the ω-3 fatty acid dose and baseline BMI explained 16.1% of the inter-individual variability in the fold change of colonic PGE2post-supplementation. Increases in mRNA gene expression after supplementation were, however, modest and were not associated with changes in PGE2. When baseline expression ofPTGS1, PTGS2andHPGDgenes was included in the linear regression model containing dose and BMI, onlyPTGS2, the gene coding for the inducible form cyclooxygenase, was a significant predictor. Higher relative expression ofPTGS2predicted greater decreases in colonic PGE2, accounting for an additional 13.6% of the inter-individual variance. In the final step of the regression model, greater decreases in total colonic fatty acid concentrations predicted greater decreases in colonic PGE2, contributing to an additional 18.7% of the variance. Overall, baseline BMI, baseline expression ofPTGS2and changes in colonic total fatty acids together accounted for 48% of the inter-individual variability in the change in colonic PGE2. This is consistent with biochemical data showing that fatty acids which are not substrates for cyclooxygenases can activate cyclooxygenase-2 allosterically. Further clinical trials are needed to elucidate the factors that regulate the fatty acid milieu of the human colon and how this interacts with key lipid metabolizing enzymes. Given the central role of PGE2in colon carcinogenesis, these pathways may also impact on colon cancer prevention by other dietary and pharmacological approaches.
机译:该研究评估了调节前列腺素(PG)E2的主要基因的mRNA表达是否与ω-3(ω-3)脂肪酸的结肠粘膜PGE2AWER膳食补充剂的降低有关。使用具有个性化剂量的个性化剂量进行补充,使用预期降低结肠PGE2By 50%的个性化剂量来补充12周。在逐步线性回归模型中,ω-3脂肪酸剂量和基线BMI在结肠PGE2POST-QoSt-Qoost-补充的折叠变化中解释了16.1%的间间变异性。然而,在补充后,MRNA基因表达的增加是适度的,并且与PGE2的变化无关。当含有剂量和BMI的线性回归模型中包含基线表达,PTGS2ANDHPGDGENES含有剂量和BMI的线性回归模型时,对于诱导型环氧化酶的基因编码,是一种重要的预测因子。结肠PGE2的PTEGS2预测的相对表达更高,占间间方差的额外13.6%。在回归模型的最后步骤中,总结肠脂肪酸浓度的更大降低预测结肠PGE2的更大减少,促进了额外的18.7%的方差。总而言之,基线BMI,基线表达2和结肠总脂肪酸的变化在一起占结肠PGE2变化中的间间可变异的48%。这与生物化学数据一致,所述生化数据显示不用于环氧盐的底物的脂肪酸可以设计成体激活环氧氢酶-2。需要进一步的临床试验来阐明调节人结肠的脂肪酸环境的因素以及这与关键脂质代谢酶的相互作用。鉴于PGE2IN结肠癌的中心作用,这些途径也可能影响其他膳食和药理学方法的结肠癌预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号